Drug profile · INN
clindamycin phosphate
CLINDAMYCIN PHOSPHATE
clindamycin phosphate (CLINDAMYCIN PHOSPHATE) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — clindamycin phosphate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 2
- Programs
- 0
- Data quality
- 0.89
Quick answer
clindamycin phosphate (CLINDAMYCIN PHOSPHATE) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is clindamycin phosphate?
clindamycin phosphate (CLINDAMYCIN PHOSPHATE) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for clindamycin phosphate?
CLINDAMYCIN PHOSPHATE is a marketed brand name for clindamycin phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clindamycin phosphate?
clindamycin phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.